In Brief: MiniMed
This article was originally published in The Gray Sheet
MiniMed: Names Terrance Gregg president and chief operating officer, filling a position left vacant by Peter Rule in October 1995. Gregg joined MiniMed in September 1994 as the firm's VP-regulatory affairs and clinical research. Before joining MiniMed, he served as VP-governmental affairs for Smith & Nephew's Ioptex Research division...
You may also be interested in...
Among four FDA regulatory items withdrawn from OMB review is “Cannabidiol Enforcement Policy; Draft Guidance for Industry,” which the agency submitted in July 2020.
A report from the US FDA says the agency will focus on updating its premarket submission portal, training staff and taking additional steps to start taking in applications for ASCA pilot participant sponsors.
With a late-stage compound on its hands, MGB is currently in discussions with several biotech and pharma companies and also with venture capitalists to continue late-stage development of a novel antibiotic which could transform treatment of Clostridium difficile.